A study showed that mortality risk was reduced by 59% for patients who underwent complete metastasectomy compared with those who did not. Patients with metastatic renal cell carcinoma (mRCC) who ...

In an attempt to search for the evidence available in the literature to support an aggressive locoregional treatment for patients with pulmonary metastases, in 2005 the council of ESTS approved the ...

Source: Getty Images There is evidence to support the role of metastasectomy in providing patients with mRCC an improvement in certain clinical outcomes. The decision to pursue metastasectomy can be ...

Since the use of vascular endothelial growth factor (VEGF)-targeted therapy became an option for frontline treatment of metastatic renal cell carcinoma (RCC) in the early 2000s, the role of ...

A pilot randomized study evaluating nivolumab (nivo) or nivo + bevacizumab (bev) or nivo + ipilimumab (ipi) in patients with metastatic renal cell carcinoma (MRCC) eligible for cytoreductive ...

Pulmonary metastasectomy has become an established component of multidisciplinary care for selected patients with colorectal cancer that has spread to the lungs. The procedure involves surgical ...

Although new treatments can prolong progression-free and overall survival in patients with renal cell carcinoma (RCC), the cure rate remains low and surgical resection of the primary tumor and ...

New Delhi: Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC), a leading institute in cancer research and treatment in India, recently organised its first workshop on ND-YAG Laser Lung ...

Pulmonary metastasectomy is common practice among surgeons, comprising nearly 15% of all lung resections. Pulmonary metastasectomy from a primary tumor elsewhere is widely believed to improve survival ...

Altered circadian rhythm in rest and activity (CircAct): Independent prognostic value for survival in patients (pts) with metastatic colorectal cancer (MCC) Forty eight patients (24 males and 24 ...